Variables of interest | Community | Workplace | ||||||
---|---|---|---|---|---|---|---|---|
 | n(%) poor treatment outcomes | Unadjusted OR | 95% CI | p-value | n(%) poor treatment outcomes | Unadjusted OR | 95% CI | p-value |
Distal level | Â | Â | Â | Â | Â | Â | Â | Â |
Sex | Â | Â | Â | Â | Â | Â | Â | Â |
   Female | 29/152(19.1%) | 1 | - | 0.10 | 0/6 (0%) | 1 | - | . |
   Male | 9/75 (12.0%) | 0.58 | 0.26-1.29 |  | 47/111(42.3%) | . | . |  |
Age (years) | Â | Â | Â | Â | Â | Â | Â | Â |
   <35 | 18/96(18.8%) | 1 | - | 0.63* | 10/23(43.5%) | 1 | - | 0.28* |
   34-45 | 11/81(13.6%) | 0.68 | 0.30-1.54 |  | 7/26(26.9%) | 0.48 | 0.15-1.58 |  |
   >45 | 9/50(18.0%) | 0.95 | 0.39-2.30 |  | 30/68(44.1%) | 1.02 | 0.40-2.66 |  |
Education (years) | Â | Â | Â | Â | Â | Â | Â | Â |
   0-6 | 6/36(16.7%) | 1 | - | 0.85* | 31/55(56.4%) | 1 | - | <0.001* |
   7-10 | 14/75(16.7%) | 1.15 | 0.40-3.28 |  | 11/45(24.4%) | 0.25 | 0.11-0.59 |  |
   >10 | 18/116(15.5%) | 0.92 | 0.33-2.52 |  | 5/17(29.4%) | 0.32 | 0.10-1.04 |  |
Alcohol consumption/week (units) | Â | Â | Â | Â | Â | Â | Â | Â |
   No alcohol | 27/183(14.8%) | 1 | - | 0.02†| 29/69(42.0%) | 1 | - | 0.87 |
   1-20 units | 6/32(18.8%) | 1.33 | 0.50-3.54 |  | 8/22(36.4%) | 0.79 | 0.29-2.12 |  |
   >21 units | 5/11(45.5%) | 4.81 | 1.37-16.89 |  | 10/26(38.5%) | 0.86 | 0.34-2.17 |  |
Time since first HIV test in community programme (months)a | Â | Â | Â | Â | Â | Â | Â | Â |
   <6 | 10/74(13.4%) | 1 | - | 0.27* | n.a. | n.a. | n.a. | n.a. |
   6-24 | 10/72(13.9%) | 1.03 | 0.40-2.65 |  |  |  |  |  |
   >24 | 18/81(22.2%) | 1.82 | 0.78-4.27 |  |  |  |  |  |
Time since first HIV test in workplace programme (months)a | Â | Â | Â | Â | Â | Â | Â | Â |
   <0.5 | n.a. | n.a. | n.a. | n.a. | 10/19(52.6%) | 1 | - | 0.02 |
   0.5-3 |  |  |  |  | 13/47(27.7%) | 0.34 | 0.11-1.04 |  |
   >3 |  |  |  |  | 22/46(47.8%) | 0.83 | 0.28-2.41 |  |
Know anyone who died of HIV | Â | Â | Â | Â | Â | Â | Â | Â |
   Yes | 28/168(16.7%) | 1 | - | 0.79 | 25/80(31.3%) | 1 | - | <0.001 |
   No/not sure | 8/53(15.1%) | 0.89 | 0.38-2.09 |  | 22/36(61.1%) | 3.46 | 1.52-7.85 |  |
Know someone on ART | Â | Â | Â | Â | Â | Â | Â | Â |
   No | 26/144(19.6%) | 1 | - | 0.18 | 25/57(43.9%) | 1 | - | 0.33 |
   Yes | 12/94(12.8%) | 0.60 | 0.29-1.26 |  | 7/22(31.8%) | 0.60 | 0.21-1.69 |  |
Informed that being tested for HIV | Â | Â | Â | Â | Â | Â | Â | Â |
   Yes | 31/201(15.4%) | 1 | - | 0.17 | 44/114(38.6%) | 1 | - | . |
   No/not sure | 7/26(26.9%) | 2.02 | 0.78-5.21 |  | 1/1(100.0%) | . | . |  |
Satisfied with programme services | Â | Â | Â | Â | Â | Â | Â | Â |
   Agree or strongly agree | 34/173(19.7%) | 1 | - | 0.06‡ | 16/57(28.1%) | 1 | - | 0.01‡ |
   Disagree or strongly disagree | 0/16(0%) | . | . |  | 6/8(75.0%) | 7.78 | 1.40-42.14 |  |
   Don't know | 4/38(10.5%) | 0.48 | 0.16-1.45 |  | 25/52(48.1%) | 2.37 | 1.10-5.25 |  |
Intermediate level | Â | Â | Â | Â | Â | Â | Â | Â |
A healthy looking person can have HIV | Â | Â | Â | Â | Â | Â | Â | Â |
   Yes | 32/206(15.5%) | 1 | - | 0.15 | 22/80(27.5%) | 1 | - | 0.001 |
   Not/not sure | 6/21(28.6%) | 2.18 | 0.79-6.03 |  | 22/34(64.7%) | 4.83 | 2.05-11.49 |  |
Belief in HIV existence | Â | Â | Â | Â | Â | Â | Â | Â |
   Yes | 36/224(16.1%) | 1 | - | 0.07‡ | 36/102(35.3%) | 1 | - | 0.02 |
   No/not sure | 2/3(66.8%) | 10.44 | 0.92-118.25 |  | 11/14(78.6%) | 6.72 | 1.76-25.66 |  |
Belief in own HIV status | Â | Â | Â | Â | Â | Â | Â | Â |
   Yes | 35/221(15.7%) | 1 | - | 0.06‡ | 37/102(36.3%) | 1 | - | 0.03 |
   No/not sure | 3/6(50.0%) | 5.31 | 1.03-27.41 |  | 10/15(66.7%) | 3.51 | 1.12-11.06 |  |
A traditional healer can treat HIV | Â | Â | Â | Â | Â | Â | Â | Â |
   Disagree/strongly disagree | 24/149(16.1%) | 1 | - | 0.76‡ | 17/63(27.0%) | 1 | - | 0.01* |
   Agree/strongly agree | 2/9(22.2%) | 1.49 | 0.29-7.60 |  | 10/18(55.6%) | 3.38 | 1.14-10.00 |  |
   Not sure/don't know | 12/169(17.4%) | left1.10 | 0.51-2.35 |  | 20/36(55.6%) | 3.38 | 1.43-8.00 |  |
Consulted traditional healer in past year | Â | Â | Â | Â | Â | Â | Â | Â |
   No | 25/170(14.7%) | 1 | - | 0.15 | 22/60(36.7%) | 1 | - | 0.43 |
   Yes | 13/56(23.2%) | 1.75 | 0.83-3.72 |  | 25/57(43.9%) | 1.35 | 0.64-2.83 |  |
Proximate level | Â | Â | Â | Â | Â | Â | Â | Â |
Effect of ART on health | Â | Â | Â | Â | Â | Â | Â | Â |
   Feel better | 22/134(16.4%) | 1 | - | 0.85 | 26/87(29.9%) | 1 | - | <0.001 |
   Not sure/don't know | 16/92(17.4%) | 1.07 | 0.53-2.17 |  | 21/30(70.0%) | 5.47 | 2.21-13.54 |  |
ART can cure HIV | Â | Â | Â | Â | Â | Â | Â | Â |
   No | 23/153(15.0%) | 1 | - | 0.33 | 21/65(32.3%) | 1 | - | 0.06 |
   Yes/not sure | 15/74(20.3%) | 1.44 | 0.70-2.95 |  | 25/50(50.0%) | 2.10 | 0.98-4.48 |  |
How difficult or easy will it be to adhere? | Â | Â | Â | Â | Â | Â | Â | Â |
   Easy/very easy | 36/197(18.3%) | 1 | - | 0.08‡ | 24/76(31.6%) | 1 | - | 0.01 |
   Difficult/very difficult/not sure | 2/30(6.7%) | 0.32 | 0.07-1.40 |  | 23/41(56.1%) | 2.80 | 1.30-6.10 |  |
Disclosed HIV status | Â | Â | Â | Â | Â | Â | Â | Â |
   Yes | 36/222(16.2%) | 1 | - | 0.20‡ | 18/56(32.1%) | 1 | - | 0.08 |
   No | 2/5(40.0%) | 3.44 | 0.56-21.35 |  | 29/60(49.3%) | 1.97 | 0.93-4.20 |  |
Disclosed the initiation of ART | Â | Â | Â | Â | Â | Â | Â | Â |
   Yes | 29/196(14.8%) | 1 | - | 0.09 | 9/37(24.3%) | 1 | - | 0.02 |
   No | 8/29(27.5%) | 2.19 | 0.89-5.42 |  | 38/80(47.5%) | 2.81 | 1.17-6.71 |  |
Social support for taking ART | Â | Â | Â | Â | Â | Â | Â | Â |
   Yes | 37/222(16.7%) | 1 | - | 1.00‡ | 13/39(33.3%) | 1 | - | 0.16 |
   No/not sure | 1/5(20.0%) | 1.25 | 0.14-11.50 |  | 20/41(48.8%) | 1.90 | 0.77-4.71 |  |
Prior TB treatment | Â | Â | Â | Â | Â | Â | Â | Â |
   No | 25/117(21.4%) | 1 | - | 0.06 | 24/59(40.7%) | 1 | - | 0.91 |
   Yes | 13/109(11.9%) | 0.50 | 0.24-1.03 |  | 8/19(42.1%) | 1.06 | 0.37-3.03 |  |
Adherence to prior chronic treatment | Â | Â | Â | Â | Â | Â | Â | Â |
   Yes | 16/135(11.9%) | 1 | - | 0.06* | 21/51(41.2%) | 1 | - | 0.85‡ |
   No | 7/29(24.1%) | 2.40 | 0.87-6.41 |  | 26/66(39.4%) | 0.93 | 0.44-1.96 | . |
   Not prescribed prior treatment | 15/63(23.8%) | 2.30 | 1.07-5.07 |  | 0 | . | . |  |
Sharing medicines with family and friends | Â | Â | Â | Â | Â | Â | Â | Â |
   Never/rarely | 37/212(17.5%) | 1 | - | 0.4‡ | 18/62(29.0%) | 1 | - | 0.01 |
   Sometimes/often/always | 1/14(7.1%) | 0.36 | 0.04-2.87 |  | 25/47(53.2%) | 2.78 | 1.26-6.14 |  |
Biological variables | Â | Â | Â | Â | Â | Â | Â | Â |
CD4 count at baseline (cells/mm3) | Â | Â | Â | Â | Â | Â | Â | Â |
<100 | 18/111(16.2%) | 1 | - | 0.78* | 8/24(33.3%) | 1 | - | 0.10* |
100-200 | 18/99(18.2%) | 1.15 | 0.56-2.35 | Â | 24/46(52.2%) | 2.18 | 0.78-6.09 | Â |
>200 | 2/17(11.8%) | 0.69 | 0.14-3.28 | Â | 15/47(31.9%) | 0.94 | 0.33-2.67 | Â |
Viral load at baseline (copies/ml) | Â | Â | Â | Â | Â | Â | Â | Â |
<100,000 | 21/105(20.0%) | 1 | - | 0.22 | 33/79(41.8%) | 1 | - | 0.61 |
≥ 100,000 | 17/122(13.9%) | 0.65 | 0.32-1.31 |  | 14/38(36.8%) | 0.81 | 0.37-1.80 |  |